BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 2982917)

  • 1. Effect of the long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat.
    Rivier C; Vale W
    J Clin Invest; 1985 Feb; 75(2):689-94. PubMed ID: 2982917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of adrenocorticotropin secretion by insulin-induced hypoglycemia in the developing rat involves arginine vasopressin but not corticotropin-releasing factor.
    Muret L; Priou A; Oliver C; Grino M
    Endocrinology; 1992 May; 130(5):2725-32. PubMed ID: 1315256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress.
    Hauger RL; Millan MA; Lorang M; Harwood JP; Aguilera G
    Endocrinology; 1988 Jul; 123(1):396-405. PubMed ID: 2838259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ontogeny of the stress response in the rat: role of the pituitary and the hypothalamus.
    Walker CD; Perrin M; Vale W; Rivier C
    Endocrinology; 1986 Apr; 118(4):1445-51. PubMed ID: 3004915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
    Lesage J; Grino M; Bernet F; Dutriez-Casteloot I; Montel V; Dupouy JP
    J Neuroendocrinol; 1998 May; 10(5):331-42. PubMed ID: 9663647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses of the rat pituitary-adrenal axis to hypotensive infusions of corticotropin-releasing factor, vasoactive intestinal peptide and other depressor agents.
    Pralong FP; Corder R; Gaillard RC
    Regul Pept; 1991 Feb; 32(2):217-26. PubMed ID: 1852030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 3 day infusion of ACTH or CRF on the pituitary-adrenal axis.
    Silberberg S; Funder JW
    Clin Exp Pharmacol Physiol; 1988 Jan; 15(1):15-21. PubMed ID: 2482798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary and adrenal responses to pulsatile ovine corticotropin-releasing factor administered to fetal sheep.
    Brooks AN; Challis JR; Norman LJ
    Endocrinology; 1987 Jun; 120(6):2383-8. PubMed ID: 3032589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproductive functions in the adult male rats after prolonged intraventricular administration of corticotropin-releasing factor (CRF).
    Miśkowiak B; Janecki A; Jakubowiak A; Limanowski A
    Exp Clin Endocrinol; 1986 Nov; 88(1):25-30. PubMed ID: 3493166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the frequency of ovine corticotropin-releasing factor administration on adrenocorticotropin and corticosterone secretion in the rat.
    Rivier C; Vale W
    Endocrinology; 1983 Oct; 113(4):1422-6. PubMed ID: 6311521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing hormone and the sympathoadrenal system are major mediators in the effects of peripherally administered exendin-4 on the hypothalamic-pituitary-adrenal axis of male rats.
    Gil-Lozano M; Romaní-Pérez M; Outeiriño-Iglesias V; Vigo E; González-Matías LC; Brubaker PL; Mallo F
    Endocrinology; 2014 Jul; 155(7):2511-23. PubMed ID: 24731096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of chronic exercise on the pituitary-adrenocortical response in conscious rats.
    Watanabe T; Morimoto A; Sakata Y; Wada M; Murakami N
    J Physiol; 1991 Aug; 439():691-9. PubMed ID: 1654420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological role of corticotropin-releasing factor in the control of adrenocorticotropin-mediated corticosterone release from the rat adrenal gland.
    van Oers JW; Hinson JP; Binnekade R; Tilders FJ
    Endocrinology; 1992 Jan; 130(1):282-8. PubMed ID: 1309333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF).
    Rivier C; Bruhn T; Vale W
    J Pharmacol Exp Ther; 1984 Apr; 229(1):127-31. PubMed ID: 6323684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the paraventricular nucleus of the hypothalamus in the alteration of neuroendocrine functions induced by intermittent footshock or interleukin.
    Rivest S; Rivier C
    Endocrinology; 1991 Oct; 129(4):2049-57. PubMed ID: 1655391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosterone-induced changes in hypothalamic corticotropin-releasing factor (CRF) content after stress.
    Sato T; Sato M; Shinsako J; Dallman MF
    Endocrinology; 1975 Aug; 97(2):265-74. PubMed ID: 169120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):787-94. PubMed ID: 1847212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic stimulation of the pituitary-adrenal axis in rats by interleukin-1 beta infusion: in vivo and in vitro studies.
    Sweep CG; van der Meer MJ; Hermus AR; Smals AG; van der Meer JW; Pesman GJ; Willemsen SJ; Benraad TJ; Kloppenborg PW
    Endocrinology; 1992 Mar; 130(3):1153-64. PubMed ID: 1311230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):795-800. PubMed ID: 1847213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.